Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Connective tissue growth factor (CCN2) is a major pro-fibrotic factor that frequently acts downstream of transforming growth factor beta (TGF-beta)-mediated fibrogenic pathways. Much of our knowledge of CCN2 in fibrosis has come from studies in which its production or activity have been experimentally attenuated. These studies, performed both in vitro and in animal models, have demonstrated the utility of pharmacological inhibitors (e.g. tumor necrosis factor alpha (TNF-alpha), prostaglandins, peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists, statins, kinase inhibitors), neutralizing antibodies, antisense oligonucleotides, or small interfering RNA (siRNA) to probe the role of CCN2 in fibrogenic pathways. These investigations have allowed the mechanisms regulating CCN2 production to be more clearly defined, have shown that CCN2 is a rational anti-fibrotic target, and have established a framework for developing effective modalities of therapeutic intervention in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319 · cited 5×
“…actions of TNF-α were initially attributed to interference of TGF-β pathways either by NF-κB-mediated induction of Smad7 or JNKmediated suppression of Smad 3 (Leask and Abraham 2004), the data now suggest that these pathways are overridden or inoperative under some circumstances in some cell types.”
BackgroundInfluentialFunctions and mechanisms of action of CCN matricellular proteins
Chen, C.-C., & Lau, L. F. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.025 · Cited by 549 · cited 2×
“Since CCN2 is a multi-modular matricellular protein, it probably resides in the ECM or tethered to the cell surface via integrins, heparan sulfate proteoglycans, and other receptors where it likely acts as a binding partner for other cell regulatory molecules (Chen and Lau 2008).”
BackgroundGhosh, A. K., Bhattacharyya, S., Lakos, G., Chen, S., Mori, Y., & Varga, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20104 · Cited by 201 · cited 2×
“However, experimental studies of PPAR-γ using the natural ligand 15-deoxy-Δ(12,14) prostaglandin J2 or synthetic ligands such as rosiglitazone, pioglitazone, or GW7845 have shown that PPAR-γ acts in a variety of cell types where it can mediate suppression of basal or TGF-β-stimulated collagen synthesis in vitro or in…”
Identification of a Gene Family Regulated by Transforming Growth Factor-β
Brunner, A., Chinn, J., Neubauer, M., & Purchio, A. F. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.293 · Cited by 124 · cited 2×
“Since the recognition almost 20 years ago that connective tissue growth factor (CCN2) mRNA is induced in cultured fibroblasts by transforming growth factor beta (TGF-β) (Brunner et al. 1991), there has been a concerted effort to understand the mechanistic basis of this relationship and to explore its in vivo consequen…”
BackgroundLiang, Y., Li, C., Guzman, V. M., Evinger, A. J., Protzman, C. E., Krauss, A. H.-P., & Woodward, D. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301009200 · Cited by 75 · cited 2×
“For example, the action of PGF2α in the cat iris is associated with increased CCN2 expression (Liang et al. 2003) while gingival fibroblasts are resistant to PGmediated CCN2 inhibition because the cAMP pathway is poorly coupled to the ras/MEK/ERK pathway and because PGE2 acts via the EP3 receptor…”
BackgroundKaesler, S., Bugnon, P., Gao, J., Murphy, P. M., Goppelt, A., & Werner, S. (2004) · Wound Repair and Regeneration · doi:10.1111/j.1067-1927.2004.012112.x · Cited by 50
Role of connective tissue growth factor in breast implant elastomer capsular formation
Mazaheri, M. K., Schultz, G. S., Blalock, T. D., Caffee, H. H., & Chin, G. A. (2003) · Annals of Plastic Surgery · doi:10.1097/01.sap.0000046781.75625.69 · Cited by 43
Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats
Wang, H., Dan, Z., & Jiang, H. (2008) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-008-0514-x · Cited by 25 · cited 2×
“2008), while all-trans retinoic acid exerted anti-fibrotic effects in the liver and was associated with decreased CCN2 and TGF-β production (Wang et al. 2008).”
Background
Cited by
Leask, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.217737 · Cited by 667
Lipson, K. E., Wong, C., Teng, Y., & Spong, S. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s24 · Cited by 575
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Jun, J.-I., & Lau, L. F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3599 · Cited by 568
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease
Wang, Q., Usinger, W., Nichols, B., Gray, J., Xu, L., Seeley, T. W., Brenner, M., Guo, G., Zhang, W., Oliver, N., et al. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-4 · Cited by 278
Chen, L., Charrier, A., Zhou, Y., Chen, R., Yu, B., Agarwal, K., Tsukamoto, H., Lee, J. L., Paulaitis, M. E., & Brigstock, D. R. (2014) · Hepatology · doi:10.1002/hep.26768 · Cited by 264
Self-citation
Metadata
- Authors
- Brigstock, D. R.
- Venue
- Journal of Cell Communication and Signaling
- Publisher
- Wiley
- Published
- 2009-03
- Volume
- 3
- Issue
- 1
- Pages
- 5-18
- ISSN
- 1873-9601 (ISSN-L)
- 1873-961X
- OpenAlex
- W2014244822
- Cited by
- 69
- References
- 8
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. https://app.cochat.ai/papers/10.1007/s12079-009-0043-9
- The paper
- Brigstock, D. R. (2009). Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. Journal of Cell Communication and Signaling. https://doi.org/10.1007/s12079-009-0043-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.